nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—Intraocular pressure increased—Octreotide—thymus cancer	0.0374	0.0472	CcSEcCtD
Fluticasone Propionate—Multiple fractures—Octreotide—thymus cancer	0.0283	0.0357	CcSEcCtD
Fluticasone Propionate—Fracture—Octreotide—thymus cancer	0.0283	0.0357	CcSEcCtD
Fluticasone Propionate—Influenza-like symptoms—Octreotide—thymus cancer	0.023	0.029	CcSEcCtD
Fluticasone Propionate—Throat sore—Octreotide—thymus cancer	0.0228	0.0288	CcSEcCtD
Fluticasone Propionate—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0226	0.0285	CcSEcCtD
Fluticasone Propionate—Stinging—Octreotide—thymus cancer	0.0203	0.0256	CcSEcCtD
Fluticasone Propionate—Endocrine disorder—Octreotide—thymus cancer	0.0199	0.025	CcSEcCtD
Fluticasone Propionate—Contusion—Octreotide—thymus cancer	0.0189	0.0238	CcSEcCtD
Fluticasone Propionate—Viral infection—Octreotide—thymus cancer	0.0182	0.023	CcSEcCtD
Fluticasone Propionate—Oropharyngeal pain—Octreotide—thymus cancer	0.0181	0.0228	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Octreotide—thymus cancer	0.0179	0.0225	CcSEcCtD
Fluticasone Propionate—Wheezing—Octreotide—thymus cancer	0.016	0.0201	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Octreotide—thymus cancer	0.016	0.0201	CcSEcCtD
Fluticasone Propionate—Candida infection—Octreotide—thymus cancer	0.0157	0.0198	CcSEcCtD
Fluticasone Propionate—Hyperkinesia—Octreotide—thymus cancer	0.0144	0.0181	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Octreotide—thymus cancer	0.0138	0.0174	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Octreotide—thymus cancer	0.0137	0.0173	CcSEcCtD
Fluticasone Propionate—Nasal congestion—Octreotide—thymus cancer	0.0131	0.0165	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Octreotide—thymus cancer	0.0123	0.0156	CcSEcCtD
Fluticasone Propionate—Irritability—Octreotide—thymus cancer	0.0114	0.0144	CcSEcCtD
Fluticasone Propionate—PLA2G4A—hematopoietic system—thymus cancer	0.0112	0.0542	CbGeAlD
Fluticasone Propionate—SERPINA6—hematopoietic system—thymus cancer	0.0111	0.054	CbGeAlD
Fluticasone Propionate—Cramp muscle—Octreotide—thymus cancer	0.0108	0.0136	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Octreotide—thymus cancer	0.0107	0.0135	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Octreotide—thymus cancer	0.0104	0.0131	CcSEcCtD
Fluticasone Propionate—Asthma—Octreotide—thymus cancer	0.0103	0.013	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Octreotide—thymus cancer	0.0102	0.0128	CcSEcCtD
Fluticasone Propionate—Bronchitis—Octreotide—thymus cancer	0.00993	0.0125	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Octreotide—thymus cancer	0.0099	0.0125	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Octreotide—thymus cancer	0.0096	0.0121	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Octreotide—thymus cancer	0.00932	0.0117	CcSEcCtD
Fluticasone Propionate—Pneumonia—Octreotide—thymus cancer	0.00926	0.0117	CcSEcCtD
Fluticasone Propionate—NR3C2—hematopoietic system—thymus cancer	0.00909	0.0441	CbGeAlD
Fluticasone Propionate—Conjunctivitis—Octreotide—thymus cancer	0.00895	0.0113	CcSEcCtD
Fluticasone Propionate—Epistaxis—Octreotide—thymus cancer	0.00868	0.0109	CcSEcCtD
Fluticasone Propionate—Sinusitis—Octreotide—thymus cancer	0.00864	0.0109	CcSEcCtD
Fluticasone Propionate—PGR—hematopoietic system—thymus cancer	0.00845	0.041	CbGeAlD
Fluticasone Propionate—PLA2G4A—pituitary gland—thymus cancer	0.00829	0.0402	CbGeAlD
Fluticasone Propionate—SERPINA6—pituitary gland—thymus cancer	0.00826	0.04	CbGeAlD
Fluticasone Propionate—Hypoaesthesia—Octreotide—thymus cancer	0.00822	0.0104	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Octreotide—thymus cancer	0.0082	0.0103	CcSEcCtD
Fluticasone Propionate—PGR—epithelium—thymus cancer	0.00773	0.0374	CbGeAlD
Fluticasone Propionate—Cardiac disorder—Octreotide—thymus cancer	0.00767	0.00967	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Octreotide—thymus cancer	0.00747	0.00941	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Octreotide—thymus cancer	0.00738	0.0093	CcSEcCtD
Fluticasone Propionate—Mental disorder—Octreotide—thymus cancer	0.00724	0.00912	CcSEcCtD
Fluticasone Propionate—Malnutrition—Octreotide—thymus cancer	0.0072	0.00907	CcSEcCtD
Fluticasone Propionate—Erythema—Octreotide—thymus cancer	0.0072	0.00907	CcSEcCtD
Fluticasone Propionate—PLA2G4A—bone marrow—thymus cancer	0.00717	0.0347	CbGeAlD
Fluticasone Propionate—PLA2G4A—thyroid gland—thymus cancer	0.00715	0.0346	CbGeAlD
Fluticasone Propionate—SERPINA6—bone marrow—thymus cancer	0.00714	0.0346	CbGeAlD
Fluticasone Propionate—Muscle spasms—Octreotide—thymus cancer	0.00692	0.00872	CcSEcCtD
Fluticasone Propionate—NR3C2—cardiac atrium—thymus cancer	0.0069	0.0335	CbGeAlD
Fluticasone Propionate—Vision blurred—Octreotide—thymus cancer	0.00678	0.00854	CcSEcCtD
Fluticasone Propionate—NR3C2—pituitary gland—thymus cancer	0.00674	0.0327	CbGeAlD
Fluticasone Propionate—Tremor—Octreotide—thymus cancer	0.00674	0.00849	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Octreotide—thymus cancer	0.00668	0.00841	CcSEcCtD
Fluticasone Propionate—Agitation—Octreotide—thymus cancer	0.00661	0.00833	CcSEcCtD
Fluticasone Propionate—NR3C1—neck—thymus cancer	0.00655	0.0317	CbGeAlD
Fluticasone Propionate—PLA2G4A—lung—thymus cancer	0.00649	0.0315	CbGeAlD
Fluticasone Propionate—Malaise—Octreotide—thymus cancer	0.00649	0.00818	CcSEcCtD
Fluticasone Propionate—SERPINA6—lung—thymus cancer	0.00647	0.0313	CbGeAlD
Fluticasone Propionate—Palpitations—Octreotide—thymus cancer	0.00636	0.00801	CcSEcCtD
Fluticasone Propionate—Cough—Octreotide—thymus cancer	0.00628	0.00791	CcSEcCtD
Fluticasone Propionate—PGR—pituitary gland—thymus cancer	0.00627	0.0304	CbGeAlD
Fluticasone Propionate—Hypertension—Octreotide—thymus cancer	0.00621	0.00783	CcSEcCtD
Fluticasone Propionate—Chest pain—Octreotide—thymus cancer	0.00613	0.00772	CcSEcCtD
Fluticasone Propionate—Arthralgia—Octreotide—thymus cancer	0.00613	0.00772	CcSEcCtD
Fluticasone Propionate—Anxiety—Octreotide—thymus cancer	0.0061	0.00769	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00608	0.00767	CcSEcCtD
Fluticasone Propionate—Discomfort—Octreotide—thymus cancer	0.00605	0.00763	CcSEcCtD
Fluticasone Propionate—Dry mouth—Octreotide—thymus cancer	0.00599	0.00755	CcSEcCtD
Fluticasone Propionate—PGR—lymphoid tissue—thymus cancer	0.00595	0.0288	CbGeAlD
Fluticasone Propionate—Anaphylactic shock—Octreotide—thymus cancer	0.00587	0.0074	CcSEcCtD
Fluticasone Propionate—Oedema—Octreotide—thymus cancer	0.00587	0.0074	CcSEcCtD
Fluticasone Propionate—Infection—Octreotide—thymus cancer	0.00583	0.00735	CcSEcCtD
Fluticasone Propionate—NR3C2—thyroid gland—thymus cancer	0.00581	0.0282	CbGeAlD
Fluticasone Propionate—Nervous system disorder—Octreotide—thymus cancer	0.00576	0.00726	CcSEcCtD
Fluticasone Propionate—Tachycardia—Octreotide—thymus cancer	0.00573	0.00722	CcSEcCtD
Fluticasone Propionate—Skin disorder—Octreotide—thymus cancer	0.0057	0.00719	CcSEcCtD
Fluticasone Propionate—PGR—thyroid gland—thymus cancer	0.0054	0.0262	CbGeAlD
Fluticasone Propionate—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00535	0.00674	CcSEcCtD
Fluticasone Propionate—NR3C2—lung—thymus cancer	0.00528	0.0256	CbGeAlD
Fluticasone Propionate—Dyspnoea—Octreotide—thymus cancer	0.00524	0.0066	CcSEcCtD
Fluticasone Propionate—Pain—Octreotide—thymus cancer	0.00502	0.00633	CcSEcCtD
Fluticasone Propionate—CYP3A5—hematopoietic system—thymus cancer	0.00491	0.0238	CbGeAlD
Fluticasone Propionate—PGR—lung—thymus cancer	0.00491	0.0238	CbGeAlD
Fluticasone Propionate—NR3C1—hematopoietic system—thymus cancer	0.00488	0.0236	CbGeAlD
Fluticasone Propionate—Feeling abnormal—Octreotide—thymus cancer	0.00484	0.0061	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Octreotide—thymus cancer	0.0048	0.00605	CcSEcCtD
Fluticasone Propionate—Urticaria—Octreotide—thymus cancer	0.00467	0.00588	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Octreotide—thymus cancer	0.00464	0.00585	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Octreotide—thymus cancer	0.00464	0.00585	CcSEcCtD
Fluticasone Propionate—NR3C1—epithelium—thymus cancer	0.00446	0.0216	CbGeAlD
Fluticasone Propionate—PLA2G4A—lymph node—thymus cancer	0.00444	0.0215	CbGeAlD
Fluticasone Propionate—Hypersensitivity—Octreotide—thymus cancer	0.00433	0.00545	CcSEcCtD
Fluticasone Propionate—Pruritus—Octreotide—thymus cancer	0.00415	0.00524	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Octreotide—thymus cancer	0.00402	0.00506	CcSEcCtD
Fluticasone Propionate—Dizziness—Octreotide—thymus cancer	0.00388	0.00489	CcSEcCtD
Fluticasone Propionate—Vomiting—Octreotide—thymus cancer	0.00373	0.0047	CcSEcCtD
Fluticasone Propionate—NR3C1—cardiac atrium—thymus cancer	0.0037	0.0179	CbGeAlD
Fluticasone Propionate—Rash—Octreotide—thymus cancer	0.0037	0.00467	CcSEcCtD
Fluticasone Propionate—Dermatitis—Octreotide—thymus cancer	0.0037	0.00466	CcSEcCtD
Fluticasone Propionate—CYP3A4—hematopoietic system—thymus cancer	0.00369	0.0179	CbGeAlD
Fluticasone Propionate—Headache—Octreotide—thymus cancer	0.00368	0.00464	CcSEcCtD
Fluticasone Propionate—NR3C1—pituitary gland—thymus cancer	0.00362	0.0175	CbGeAlD
Fluticasone Propionate—NR3C2—lymph node—thymus cancer	0.00361	0.0175	CbGeAlD
Fluticasone Propionate—Nausea—Octreotide—thymus cancer	0.00349	0.0044	CcSEcCtD
Fluticasone Propionate—NR3C1—lymphoid tissue—thymus cancer	0.00343	0.0166	CbGeAlD
Fluticasone Propionate—PGR—lymph node—thymus cancer	0.00336	0.0163	CbGeAlD
Fluticasone Propionate—NR3C1—bone marrow—thymus cancer	0.00313	0.0151	CbGeAlD
Fluticasone Propionate—NR3C1—thyroid gland—thymus cancer	0.00312	0.0151	CbGeAlD
Fluticasone Propionate—CYP3A5—lung—thymus cancer	0.00285	0.0138	CbGeAlD
Fluticasone Propionate—NR3C1—lung—thymus cancer	0.00283	0.0137	CbGeAlD
Fluticasone Propionate—NR3C1—lymph node—thymus cancer	0.00194	0.00939	CbGeAlD
